Weekly paclitaxel and pegylated liposomal doxorubicin (PLD) as first-line therapy in metastatic breast cancer

被引：0
|
作者：
Valerio, M. R.
Fulfaro, F.
Cicero, G.
Rinaldi, G.
Maiorana, O.
Spinnato, F.
Intrivici, C.
Crosta, A.
Scibilia, C.
Pizzo, T.
Vanella, P.
Gebbia, N.
机构：
[1] Dept Oncol, Palermo, Italy
[2] Univ Palermo, Palermo, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：VII147 / VII147
页数：1
相关论文
共 50 条
  • [1] Pegylated liposomal doxorubicin (PLD) and weekly paclitaxel as first line therapy in metastatic breast cancer
    Fulfaro, F.
    Valerio, M. R.
    Cicero, G.
    Rinaldi, G.
    Intrivici, C.
    Pizzo, T.
    Crosta, A.
    Scibilia, C.
    Gebbia, N.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : XI10 - XI11
  • [2] PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) AND WEEKLY PACLITAXEL (T) AS FIRST-LINE TREATMENT IN METASTATIC BREAST CANCER (MBC)
    Badalamenti, Giuseppe
    Valerio, Maria Rosaria
    Rinaldi, Gaetana
    Arcara, Carlo
    Cicero, Giuseppe
    Vizzini, Laura
    Travagliato, Maria Grazia
    Intrivici, Chiara
    Russo, Antonio
    Gulotta, Gaspare
    Gebbia, Nicola
    Fulfaro, Fabio
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 24 - 24
  • [3] Weekly paclitaxel (T) and pegylated liposomal doxorubicin (PLD) as first line treatment in metastatic breast cancer (MBC) patients.
    Fulfaro, F
    Valerio, MR
    Badalamenti, G
    Arcara, C
    Cicero, G
    Intrivici, C
    Crosta, A
    Sciortino, C
    Russo, A
    Gebbia, N
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 53S - 53S
  • [4] Weekly paclitaxel and pegylated liposomal doxorubicin in metastatic breast carcinoma
    Leonardi, V.
    Palmisano, V.
    Pepe, A.
    Usset, A.
    Savio, G.
    Laudani, A.
    Calabria, C.
    Tartaglia, L.
    Amari, P.
    Carruba, G.
    Agostara, B.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 55 - 55
  • [5] Pilot study with pegylated liposomal doxorubicin (PLD) and docetaxel as first-line treatment in patients with metastatic breast cancer (MBC)
    Mel, J. R., Sr.
    Ramos, M.
    Cueva, J.
    Castellanos, J.
    Almanza, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] Phase I-II study of pegylated liposomal doxorubicin combined with weekly paclitaxel as first-line treatment in patients with metastatic breast cancer
    Bourgeois, Hugues
    Ferru, Aurelie
    Lortholary, Alain
    Delozier, Thierry
    Boisdron-Celle, Michelle
    Abadie-Lacourtoisie, Sophie
    Joly, Florence
    Chieze, Stephanie
    Chabrun, Virginie
    Gamelin, Erick
    Tourani, Jean-Marc
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (03): : 267 - 275
  • [7] Phase II study of weekly pegylated liposomal doxorubicin and docetaxel as first-line chemotherapy for metastatic breast cancer.
    Holmes, F
    Blum, JL
    Kruger, S
    Ratnam, S
    Liu, L
    Boehm, KA
    Asmar, L
    O'Shaughnessy, JA
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S130 - S130
  • [8] Phase I/II Gemcitabine (G) with Pegylated Liposomal Doxorubicin (PLD) as first-line therapy in metastatic breast cancer (MBC) in Asian women
    Wong, Zee Wan
    Shah, Valencia A.
    Wong, Nan Soon
    Ang, Peter Cher Siang
    Silverman, Carrie
    Tan, Say Beng
    Cheung, Yin Bun
    Chowbay, Balram
    See, Hui Ti
    Khoo, Kei Siong
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 43 - 43
  • [9] Paclitaxel versus doxorubicin as first-line therapy for metastatic breast cancer
    Tanner, J
    Kuhnt, T
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2000, 176 (09) : 435 - 436
  • [10] Weekly paclitaxel, doxorubicin, and carboplatin in the first-line treatment of patients with metastatic breast cancer
    Hainsworth, JD
    Burris, HA
    Greco, FA
    [J]. SEMINARS IN ONCOLOGY, 1999, 26 (06) : 13 - 13
12345